• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Issue #6 2015 – Digital edition

6 January 2016  •  Author(s): European Pharmaceutical Review

In the digital version of Issue #6 2015:

  • European Pharmaceutical Review issue 6 2015FOREWORD: Use of the ‘purge tool’ in assessing mutagenic impurities
    David Elder, GlaxoSmithKline and JPAG
  • MICROBIOLOGY SERIES: The limitations of the colony-forming unit in microbiology
    Tony Cundell, Microbiological Consulting LLC
    Featuring articles from Angela Panarella and Jeremy C. Simpson, UCD Cell Screening Laboratory at the University College Dublin, and Horst Flotow, Hit Discovery Constance. A Screening Roundtable can be found on page 25
  • PCR: MIQE compliance in expression profiling and clinical biomarker discovery
    Irmgard Riedmaier, Melanie Spornraft, Benedikt Kirchner and Michael W. Pfaffl, Technical University of Munich
  • CONTINUOUS MANUFACTURING: Designing a novel continuous manufacturing plant with superior monitoring and control
    Ravendra Singh, Jun Zhang, Marianthi Ierapetritou and Rohit Ramachandran, State University of New Jersey
    With articles from David P. Elder, GlaxoSmithKline and JPAG, and Huiquan Wu and colleagues from the United States Food and Drug Administration. Kaiser Optical Systems discusses its opinions on PAT and Raman on page 48, and a PAT roundtable starts on page 57
  • REGULATORY INSIGHT: To float or not to float?
    Sue Staunton, James Cowper Kreston

The rest of this content is restricted to logged-in subscribers. Login or register (it's free!) to view the full content.

One response to “Issue #6 2015 – Digital edition”

  1. farukomar708 says:


Leave a reply